Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial
scientific article published on 01 March 2020
Author/s
author: Angelo Di Leo, Patrick Neven, Olivia Pagani, Aron Goldhirsch, Meredith M Regan, Manuela Rabaglio, Karin Ribi, Prudence Francis, Marco Colleoni, Thomas Ruhstaller, Weixiu Luo, Daniel A Vorobiof, Jacquie Chirgwin, Ehtesham A Abdi, Arvid Carlsson, Guy Jerusalem, Vincenzo Lauro, Annelore Barbeaux, Marie-Pascale Graas, Claudio Graiff, SOLE Investigators
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.